More > Announcing a complete assay for recurrence likelihood of colorectal cancer
  • New tool to enable physicians to make more accurate therapeutic decisions
  • Analyzes patient tissue samples for a genetic signature linked to recurrence
  • A product of Ananomouse's partnership with leading hospitals and laboratory facilities
Bloodhound Praxis™ Protocol maintenance and analysis Praxis™ is a software platform developed to facilitate consensus workflows for human sample collection and analysis in the context of genomic/proteomic expression databases, phenotypic and data collection QA metrics. > Learn More
July 7, 2008 United States Department of Justice acquires international Bloodhound™ License. Ananomouse Corporation, a leading provider of computational genomic solutions, today announced the establishment of a worldwide-unlimited license for its Bloodhound technology to the US Department of Justice (DOJ).
> More
May 20, 2007 Ananomouse announces the development of clinical oncology genomic signatures. Ananomouse Corporation announced today the launch of a new initiative targeting the development of clinical oncology genomic signatures.
> More